cancerALLautoimmune diseasesCLLSLEGvHDgraft-versus-host diseaseNSG miceGPC3Medicilon’s Ethics Board
…fective allogeneic platform for CAR-based immunotherapy in both cancer and autoimmune diseases, providing a strong foundation for furt…
23,712articles mentioning diseases
125,551disease mentions
18,081distinct diseases extracted
0%of mentions human-reviewed
All extracted diseases
Showing 121–180 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.
Cerebral Palsy49T1D48Schizophrenia48Acute Kidney Injury48Acute myocardial infarction48ICH47Hepatitis B47Congenital Heart Disease47TBI46GOnorrhoea46CD46Antimicrobial Resistance46Pulmonary Embolism46Myopia45ACS45Acute Ischaemic Stroke45Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)45PBC44Multiple myeloma44Delirium43Idiopathic Pulmonary Fibrosis43PTSD43HFREF43Severe Asthma43Advanced Cancer43Psoriasis43Pancreatic Ductal Adenocarcinoma (PDAC)43HNSCC42Scleroderma42Chronic diseases42CF41Metabolic Syndrome41Arthritis41Myasthenia Gravis41Chronic Disease41Dyslipidaemia41PSA40Myocarditis40TNBC40Diabetic Retinopathy40Bipolar disorder40Metabolic Dysfunction-Associated Steatotic Liver Disease40Amyotrophic Lateral Sclerosis40Pancreatitis39Decompensated Cirrhosis39Measles39LN39Atherosclerosis39Attention-Deficit/Hyperactivity Disorder39Chronic subdural hematoma (CSDH)39ALS38SCD38Heart Disease38Pulmonary Arterial Hypertension38Antiphospholipid Syndrome38cancers38Chlamydia trachomatis38AML37Cardiomyopathy37Metastatic Melanoma37
Articles mentioning diseases
23,712 articles · page 220 of 1976COVID-19advanced/metastatic canceradvanced/metastatic solid tumorshepatocellular carcinomatype 2 diabetes mellitusECOG Performance StatusNP-101
….0002). A double-blind, randomized, placebo-controlled trial in COVID-19 patients14 demonstrated that NP-101 led to a faster decline in …
HNSCCPembrolizumabmicvo
…y pretreated patients across multiple tumor types, particularly HNSCC, with a manageable safety profile. Therefore, exploring the com…
94.6%
Acute myeloid leukemianeuroblastomaAMLNKTR-255
…Background Acute myeloid leukemia (AML) accounts for 25% of acute leukemias in children and 33% i…
BCCaBCClocally advanced or metastatic diseasecemiplimab
…nowledge and competence (K/C) related to choosing patients with BCC who should receive systemic therapies, including IOs. We used a…
metastatic melanomaCVDmyocarditisipilimumabPembrolizumabSEER 18surgical treatmentAmerican Heart AssociationN Engl J MedJ Am Coll Cardiol
…ne checkpoint inhibitors (ICIs) have revolutionized therapy for metastatic melanoma, substantially improving survival outcomes. 1 2 However, as ICI…
colorectal cancerCRCSeverance Hospital
… FOXP3+CD25+CD127– Treg cells in colorectal cancer.KRAS-mutated colorectal cancer (CRC) tumors exhibited significantly higher frequencies of both…
Small cell lung cancerSCLCataxia telangiectasiatopotecanM6620chemotherapyVX970
…Background Small cell lung cancer (SCLC) is the most aggressive subtype of lung cancer. Recent cl…
head and neck squamous cell carcinomaRenal cell carcinomanon-small cell lung cancerRCCimmunotherapyProvidence St. Joseph Health Institutional Review Board – Oregonimmunotherapy-refractory
…cell-cell interactions among a cohort of primary breast cancer, head and neck squamous cell carcinoma, non-small cell lung cancer, and RCC specimens. Putative tumor …
melanomaTalimogene laherparepvectalimogene laherparapvecpembrolizumabMassachusetts General HospitalMGHMGH Pathology Flow Core
…, Cohen S. Genetic factors associated with clinical response in melanoma patients treated with talimogene laherparapvec: a single-instit…
glioblastomaTIMP-1IACUC #2019-0042
… may serve as a novel immunoregulatory marker in the irradiated glioblastoma tumor microenvironment. Ongoing studies will determine whether …
acute myeloid leukemiaAMLazacitidinevenetoclax
…decoy for targeting survival and immune checkpoint signaling in acute myeloid leukemia. Blood. 2016. PMID: 26796361; PMCID: PMC4817311.Esposito CL, Au…